

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | melanin biosynthetic process (GO:0042438) | 6.99831684 |
| 2 | melanin metabolic process (GO:0006582) | 6.29258030 |
| 3 | secondary metabolite biosynthetic process (GO:0044550) | 5.68280831 |
| 4 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 4.47125211 |
| 5 | developmental pigmentation (GO:0048066) | 4.14996787 |
| 6 | nodal signaling pathway (GO:0038092) | 3.80758058 |
| 7 | pigment cell differentiation (GO:0050931) | 3.55784495 |
| 8 | L-amino acid import (GO:0043092) | 3.50722948 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 3.44140088 |
| 10 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 3.43486293 |
| 11 | blood vessel maturation (GO:0001955) | 3.41962653 |
| 12 | adenosine receptor signaling pathway (GO:0001973) | 3.41576572 |
| 13 | keratan sulfate catabolic process (GO:0042340) | 3.40058443 |
| 14 | negative regulation of cell killing (GO:0031342) | 3.34548308 |
| 15 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.34548308 |
| 16 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.31424245 |
| 17 | presynaptic membrane assembly (GO:0097105) | 3.28815401 |
| 18 | neuromuscular process controlling posture (GO:0050884) | 3.27970871 |
| 19 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.26174545 |
| 20 | melanocyte differentiation (GO:0030318) | 3.19855618 |
| 21 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 3.19168247 |
| 22 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.12827582 |
| 23 | melanosome organization (GO:0032438) | 3.11472943 |
| 24 | presynaptic membrane organization (GO:0097090) | 3.10939493 |
| 25 | positive regulation of protein autophosphorylation (GO:0031954) | 3.00031212 |
| 26 | detection of molecule of bacterial origin (GO:0032490) | 2.98098775 |
| 27 | oligosaccharide catabolic process (GO:0009313) | 2.97168813 |
| 28 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.95673124 |
| 29 | positive regulation of tolerance induction (GO:0002645) | 2.94870897 |
| 30 | signal peptide processing (GO:0006465) | 2.93100048 |
| 31 | pigment granule organization (GO:0048753) | 2.90630893 |
| 32 | amino acid import (GO:0043090) | 2.90307909 |
| 33 | negative regulation of neurotransmitter transport (GO:0051589) | 2.88386946 |
| 34 | activated T cell proliferation (GO:0050798) | 2.85735669 |
| 35 | negative regulation of lipid storage (GO:0010888) | 2.85541509 |
| 36 | neuronal action potential propagation (GO:0019227) | 2.83640417 |
| 37 | negative regulation of interleukin-1 production (GO:0032692) | 2.80721248 |
| 38 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.80678434 |
| 39 | negative regulation of cation channel activity (GO:2001258) | 2.80663950 |
| 40 | regulation of neuron projection regeneration (GO:0070570) | 2.79443639 |
| 41 | regulation of axon regeneration (GO:0048679) | 2.79443639 |
| 42 | phagosome maturation (GO:0090382) | 2.79342209 |
| 43 | positive regulation of receptor recycling (GO:0001921) | 2.76893454 |
| 44 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.74791340 |
| 45 | cellular extravasation (GO:0045123) | 2.74711386 |
| 46 | granulocyte activation (GO:0036230) | 2.74262147 |
| 47 | endosome to melanosome transport (GO:0035646) | 2.73489644 |
| 48 | endosome to pigment granule transport (GO:0043485) | 2.73489644 |
| 49 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.73336419 |
| 50 | response to peptidoglycan (GO:0032494) | 2.71213874 |
| 51 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.71114462 |
| 52 | synaptic vesicle exocytosis (GO:0016079) | 2.70034827 |
| 53 | regulation of tolerance induction (GO:0002643) | 2.69753789 |
| 54 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.68493715 |
| 55 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.67604981 |
| 56 | neuron cell-cell adhesion (GO:0007158) | 2.67164268 |
| 57 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.66286049 |
| 58 | protein targeting to vacuole (GO:0006623) | 2.65819822 |
| 59 | protein targeting to lysosome (GO:0006622) | 2.65819822 |
| 60 | establishment of protein localization to vacuole (GO:0072666) | 2.65819822 |
| 61 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.65179819 |
| 62 | central nervous system myelination (GO:0022010) | 2.65122963 |
| 63 | axon ensheathment in central nervous system (GO:0032291) | 2.65122963 |
| 64 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.64476998 |
| 65 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.64255356 |
| 66 | glutamate secretion (GO:0014047) | 2.63922828 |
| 67 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.62013249 |
| 68 | regulation of glutamate secretion (GO:0014048) | 2.61949190 |
| 69 | substrate-dependent cell migration (GO:0006929) | 2.61875637 |
| 70 | lytic vacuole organization (GO:0080171) | 2.60888820 |
| 71 | lysosome organization (GO:0007040) | 2.60888820 |
| 72 | transferrin transport (GO:0033572) | 2.59988248 |
| 73 | phenol-containing compound biosynthetic process (GO:0046189) | 2.58884702 |
| 74 | glucosamine-containing compound catabolic process (GO:1901072) | 2.56436635 |
| 75 | response to histamine (GO:0034776) | 2.56196942 |
| 76 | neutrophil activation (GO:0042119) | 2.55861029 |
| 77 | parental behavior (GO:0060746) | 2.55726011 |
| 78 | macrophage activation involved in immune response (GO:0002281) | 2.55546142 |
| 79 | metanephric mesenchyme development (GO:0072075) | 2.54025283 |
| 80 | platelet dense granule organization (GO:0060155) | 2.53808788 |
| 81 | metanephric tubule development (GO:0072170) | 2.52836222 |
| 82 | metanephric nephron tubule development (GO:0072234) | 2.52836222 |
| 83 | negative regulation of bone resorption (GO:0045779) | 2.52470173 |
| 84 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.52309472 |
| 85 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.52309472 |
| 86 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.52309472 |
| 87 | modulation by symbiont of host immune response (GO:0052553) | 2.52309472 |
| 88 | positive regulation by symbiont of host defense response (GO:0052509) | 2.52309472 |
| 89 | modulation by symbiont of host defense response (GO:0052031) | 2.52309472 |
| 90 | phagocytosis, recognition (GO:0006910) | 2.51955674 |
| 91 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.50106646 |
| 92 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.49179428 |
| 93 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.49179428 |
| 94 | protein localization to endosome (GO:0036010) | 2.48140300 |
| 95 | neuron remodeling (GO:0016322) | 2.48006962 |
| 96 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.47706937 |
| 97 | Rap protein signal transduction (GO:0032486) | 2.47706490 |
| 98 | negative regulation of interleukin-17 production (GO:0032700) | 2.46010526 |
| 99 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.45965019 |
| 100 | proline transport (GO:0015824) | 2.45304091 |
| 101 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.44728852 |
| 102 | regulation of mononuclear cell migration (GO:0071675) | 2.44324720 |
| 103 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.43733857 |
| 104 | actin nucleation (GO:0045010) | 2.43087043 |
| 105 | tyrosine metabolic process (GO:0006570) | 2.42615893 |
| 106 | glycosphingolipid catabolic process (GO:0046479) | 2.42530374 |
| 107 | regulation of vesicle fusion (GO:0031338) | 2.41475621 |
| 108 | negative regulation of mast cell activation (GO:0033004) | 2.41377003 |
| 109 | regulation of beta-amyloid formation (GO:1902003) | 2.41171301 |
| 110 | negative regulation of protein autophosphorylation (GO:0031953) | 2.40441697 |
| 111 | ferric iron transport (GO:0015682) | 2.40429097 |
| 112 | trivalent inorganic cation transport (GO:0072512) | 2.40429097 |
| 113 | positive regulation of T cell chemotaxis (GO:0010820) | 2.40317933 |
| 114 | regulation of T cell chemotaxis (GO:0010819) | 2.40317933 |
| 115 | positive regulation of mast cell activation (GO:0033005) | 2.39895253 |
| 116 | cell adhesion mediated by integrin (GO:0033627) | 2.39568902 |
| 117 | neutrophil mediated immunity (GO:0002446) | 2.38787034 |
| 118 | intracellular pH reduction (GO:0051452) | 2.38569413 |
| 119 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.37711675 |
| 120 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.37623437 |
| 121 | negative regulation of interleukin-12 production (GO:0032695) | 2.36289241 |
| 122 | synaptic transmission, glutamatergic (GO:0035249) | 2.36226418 |
| 123 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.36027408 |
| 124 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.36002093 |
| 125 | metanephric nephron epithelium development (GO:0072243) | 2.35880770 |
| 126 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.35760205 |
| 127 | negative regulation of phagocytosis (GO:0050765) | 2.34920184 |
| 128 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.34844831 |
| 129 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.33479328 |
| 130 | response to thyroid hormone (GO:0097066) | 2.32839711 |
| 131 | microglial cell activation (GO:0001774) | 2.32562515 |
| 132 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.32282772 |
| 133 | regulation of protein autophosphorylation (GO:0031952) | 2.32091236 |
| 134 | amino sugar catabolic process (GO:0046348) | 2.30808019 |
| 135 | ketone body metabolic process (GO:1902224) | 2.30777728 |
| 136 | daunorubicin metabolic process (GO:0044597) | 2.30485358 |
| 137 | polyketide metabolic process (GO:0030638) | 2.30485358 |
| 138 | doxorubicin metabolic process (GO:0044598) | 2.30485358 |
| 139 | L-serine transport (GO:0015825) | 2.30101797 |
| 140 | regulation of mast cell activation (GO:0033003) | 2.29824480 |
| 141 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.29690996 |
| 142 | glycosylceramide metabolic process (GO:0006677) | 2.28932219 |
| 143 | pH reduction (GO:0045851) | 2.28720911 |
| 144 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.28637412 |
| 145 | respiratory burst (GO:0045730) | 2.28581045 |
| 146 | eosinophil chemotaxis (GO:0048245) | 2.28279497 |
| 147 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.27449847 |
| 148 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.26982426 |
| 149 | nerve growth factor signaling pathway (GO:0038180) | 2.26378955 |
| 150 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.25564290 |
| 151 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.25437076 |
| 152 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.24764490 |
| 153 | cellular response to fluid shear stress (GO:0071498) | 2.24643333 |
| 154 | dopamine biosynthetic process (GO:0042416) | 2.24462867 |
| 155 | myeloid cell activation involved in immune response (GO:0002275) | 2.24001803 |
| 156 | neuron-neuron synaptic transmission (GO:0007270) | 2.23761571 |
| 157 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.23265967 |
| 158 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.22197856 |
| 159 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.22121509 |
| 160 | regulation of platelet aggregation (GO:0090330) | 2.21584194 |
| 161 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.21527751 |
| 162 | regulation of macrophage cytokine production (GO:0010935) | 2.20853977 |
| 163 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.20689584 |
| 164 | sphingosine metabolic process (GO:0006670) | 2.20358508 |
| 165 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.19476358 |
| 166 | kidney mesenchyme development (GO:0072074) | 2.19220241 |
| 167 | clathrin coat assembly (GO:0048268) | 2.19147313 |
| 168 | regulation of interleukin-1 beta production (GO:0032651) | 2.18887737 |
| 169 | ER overload response (GO:0006983) | 2.18616588 |
| 170 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.18588898 |
| 171 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.18588898 |
| 172 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 2.18540749 |
| 173 | locomotory exploration behavior (GO:0035641) | 2.18390469 |
| 174 | regulation of interleukin-1 production (GO:0032652) | 2.18377756 |
| 175 | cellular response to ethanol (GO:0071361) | 2.18181017 |
| 176 | regulation of chemokine biosynthetic process (GO:0045073) | 2.17839139 |
| 177 | N-acetylneuraminate metabolic process (GO:0006054) | 2.17746185 |
| 178 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.17683229 |
| 179 | maternal behavior (GO:0042711) | 2.17482990 |
| 180 | dendritic cell migration (GO:0036336) | 2.17464060 |
| 181 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.17372856 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.51919458 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.61307735 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.55985278 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.54598565 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.33000001 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.23284366 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.15757049 |
| 8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.08629751 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.05441171 |
| 10 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.02831197 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.01178798 |
| 12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.97746787 |
| 13 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.95104076 |
| 14 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.92171283 |
| 15 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.88886813 |
| 16 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.87226343 |
| 17 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.83468650 |
| 18 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.81682555 |
| 19 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.81640886 |
| 20 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.81401498 |
| 21 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.76414582 |
| 22 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.75955908 |
| 23 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.75810100 |
| 24 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.75525167 |
| 25 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.75246739 |
| 26 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.74692665 |
| 27 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.74173407 |
| 28 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.73956988 |
| 29 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.73385899 |
| 30 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.73173441 |
| 31 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.68880072 |
| 32 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.68659911 |
| 33 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.60021090 |
| 34 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.59986665 |
| 35 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.59986665 |
| 36 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.57087531 |
| 37 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.55473616 |
| 38 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.55045970 |
| 39 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.54077374 |
| 40 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.52903430 |
| 41 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.49671091 |
| 42 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.46769806 |
| 43 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.46758917 |
| 44 | P300_19829295_ChIP-Seq_ESCs_Human | 1.46672479 |
| 45 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.44393026 |
| 46 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.42599171 |
| 47 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.42481755 |
| 48 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.42013893 |
| 49 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.38625733 |
| 50 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.37853031 |
| 51 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.37008746 |
| 52 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36726855 |
| 53 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.35745201 |
| 54 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.35745201 |
| 55 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.34563633 |
| 56 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.33708986 |
| 57 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.32555864 |
| 58 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.31806650 |
| 59 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.31579000 |
| 60 | TP53_16413492_ChIP-PET_HCT116_Human | 1.31335245 |
| 61 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.30886052 |
| 62 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.30658095 |
| 63 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.28661365 |
| 64 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.28365409 |
| 65 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.28245727 |
| 66 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.26450424 |
| 67 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.26295053 |
| 68 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.25483209 |
| 69 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.25441402 |
| 70 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.24711750 |
| 71 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.24381261 |
| 72 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.24231839 |
| 73 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.23978244 |
| 74 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.23644460 |
| 75 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.22755572 |
| 76 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.22650634 |
| 77 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.21872699 |
| 78 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.20701370 |
| 79 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.20405659 |
| 80 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.19961063 |
| 81 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.19743927 |
| 82 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.19090883 |
| 83 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.18650049 |
| 84 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.17700068 |
| 85 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.17626875 |
| 86 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.17323126 |
| 87 | AR_25329375_ChIP-Seq_VCAP_Human | 1.16255822 |
| 88 | GATA3_26560356_Chip-Seq_TH2_Human | 1.16226063 |
| 89 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.15806034 |
| 90 | * CDX2_22108803_ChIP-Seq_LS180_Human | 1.14274414 |
| 91 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13370535 |
| 92 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.13133777 |
| 93 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.12939267 |
| 94 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11647652 |
| 95 | GATA1_22025678_ChIP-Seq_K562_Human | 1.11484774 |
| 96 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.09769976 |
| 97 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.09695583 |
| 98 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.09419400 |
| 99 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.09329219 |
| 100 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08465851 |
| 101 | FUS_26573619_Chip-Seq_HEK293_Human | 1.08307975 |
| 102 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.08087739 |
| 103 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.07127682 |
| 104 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.07016890 |
| 105 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.06564307 |
| 106 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.05865837 |
| 107 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.05853837 |
| 108 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.05799532 |
| 109 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.05553075 |
| 110 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.05474430 |
| 111 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.05198501 |
| 112 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.04940368 |
| 113 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.04406946 |
| 114 | JUN_21703547_ChIP-Seq_K562_Human | 1.04344756 |
| 115 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.03944105 |
| 116 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.03306019 |
| 117 | SPI1_23127762_ChIP-Seq_K562_Human | 1.03042595 |
| 118 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.02767985 |
| 119 | RXR_22108803_ChIP-Seq_LS180_Human | 0.99202926 |
| 120 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.98489144 |
| 121 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.98482878 |
| 122 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.97749763 |
| 123 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.97252313 |
| 124 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97163784 |
| 125 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.97054919 |
| 126 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.96629146 |
| 127 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96355290 |
| 128 | KDM2B_26808549_Chip-Seq_REH_Human | 0.95713741 |
| 129 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.95016214 |
| 130 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.94734134 |
| 131 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.94452441 |
| 132 | TCF4_23295773_ChIP-Seq_U87_Human | 0.93746531 |
| 133 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.93612192 |
| 134 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93138733 |
| 135 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.92784257 |
| 136 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.89306334 |
| 137 | MYB_26560356_Chip-Seq_TH2_Human | 0.87375628 |
| 138 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.87031737 |
| 139 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.85801371 |
| 140 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.85636207 |
| 141 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.85602572 |
| 142 | CJUN_26792858_Chip-Seq_BT549_Human | 0.85494139 |
| 143 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.84680698 |
| 144 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.84042027 |
| 145 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.83699509 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003283_abnormal_digestive_organ | 4.49724070 |
| 2 | MP0004510_myositis | 3.97166120 |
| 3 | MP0005058_abnormal_lysosome_morphology | 3.65373427 |
| 4 | MP0005408_hypopigmentation | 3.39259993 |
| 5 | MP0000569_abnormal_digit_pigmentation | 3.27417822 |
| 6 | MP0006082_CNS_inflammation | 3.12204655 |
| 7 | MP0004859_abnormal_synaptic_plasticity | 3.08471418 |
| 8 | MP0003880_abnormal_central_pattern | 2.74986324 |
| 9 | MP0000371_diluted_coat_color | 2.72465284 |
| 10 | MP0003136_yellow_coat_color | 2.67415082 |
| 11 | MP0005075_abnormal_melanosome_morpholog | 2.67157459 |
| 12 | MP0002095_abnormal_skin_pigmentation | 2.31643000 |
| 13 | MP0004270_analgesia | 2.29734430 |
| 14 | MP0003172_abnormal_lysosome_physiology | 2.23192489 |
| 15 | MP0006054_spinal_hemorrhage | 2.23136553 |
| 16 | MP0009046_muscle_twitch | 2.22193420 |
| 17 | MP0002254_reproductive_system_inflammat | 2.21859927 |
| 18 | MP0002064_seizures | 2.20358796 |
| 19 | MP0004381_abnormal_hair_follicle | 2.17280345 |
| 20 | MP0003635_abnormal_synaptic_transmissio | 2.13263467 |
| 21 | MP0000920_abnormal_myelination | 2.12498163 |
| 22 | MP0005423_abnormal_somatic_nervous | 1.99071908 |
| 23 | MP0009745_abnormal_behavioral_response | 1.93000743 |
| 24 | MP0000343_altered_response_to | 1.88700508 |
| 25 | MP0002272_abnormal_nervous_system | 1.88475250 |
| 26 | MP0003690_abnormal_glial_cell | 1.88134199 |
| 27 | MP0001873_stomach_inflammation | 1.87991692 |
| 28 | MP0005671_abnormal_response_to | 1.86596538 |
| 29 | MP0005257_abnormal_intraocular_pressure | 1.83201650 |
| 30 | MP0002572_abnormal_emotion/affect_behav | 1.80795569 |
| 31 | MP0004885_abnormal_endolymph | 1.80014504 |
| 32 | MP0001968_abnormal_touch/_nociception | 1.76689329 |
| 33 | MP0003075_altered_response_to | 1.75924087 |
| 34 | MP0003828_pulmonary_edema | 1.68583457 |
| 35 | MP0004133_heterotaxia | 1.68252196 |
| 36 | MP0002419_abnormal_innate_immunity | 1.66451717 |
| 37 | MP0001324_abnormal_eye_pigmentation | 1.65892949 |
| 38 | MP0002063_abnormal_learning/memory/cond | 1.62673733 |
| 39 | MP0001905_abnormal_dopamine_level | 1.62047928 |
| 40 | MP0002736_abnormal_nociception_after | 1.61593490 |
| 41 | MP0002735_abnormal_chemical_nociception | 1.61540918 |
| 42 | MP0001835_abnormal_antigen_presentation | 1.60586925 |
| 43 | MP0005409_darkened_coat_color | 1.58356045 |
| 44 | MP0009764_decreased_sensitivity_to | 1.50912195 |
| 45 | MP0001986_abnormal_taste_sensitivity | 1.50827068 |
| 46 | MP0009780_abnormal_chondrocyte_physiolo | 1.48251315 |
| 47 | MP0003329_amyloid_beta_deposits | 1.48184659 |
| 48 | MP0005000_abnormal_immune_tolerance | 1.48182599 |
| 49 | * MP0002998_abnormal_bone_remodeling | 1.46682847 |
| 50 | MP0003183_abnormal_peptide_metabolism | 1.45667131 |
| 51 | MP0003300_gastrointestinal_ulcer | 1.45092454 |
| 52 | MP0003806_abnormal_nucleotide_metabolis | 1.43582889 |
| 53 | MP0005171_absent_coat_pigmentation | 1.40795011 |
| 54 | MP0002733_abnormal_thermal_nociception | 1.39952334 |
| 55 | MP0000604_amyloidosis | 1.39941744 |
| 56 | MP0002933_joint_inflammation | 1.38697590 |
| 57 | MP0003279_aneurysm | 1.34027476 |
| 58 | MP0002148_abnormal_hypersensitivity_rea | 1.33940782 |
| 59 | MP0010386_abnormal_urinary_bladder | 1.31513827 |
| 60 | MP0001970_abnormal_pain_threshold | 1.31207541 |
| 61 | MP0009840_abnormal_foam_cell | 1.30986725 |
| 62 | MP0000372_irregular_coat_pigmentation | 1.30279181 |
| 63 | MP0002102_abnormal_ear_morphology | 1.29745780 |
| 64 | MP0003303_peritoneal_inflammation | 1.29178248 |
| 65 | MP0001486_abnormal_startle_reflex | 1.28857357 |
| 66 | MP0003724_increased_susceptibility_to | 1.28781555 |
| 67 | MP0001501_abnormal_sleep_pattern | 1.28234906 |
| 68 | MP0004742_abnormal_vestibular_system | 1.27519844 |
| 69 | MP0002723_abnormal_immune_serum | 1.25336922 |
| 70 | * MP0002075_abnormal_coat/hair_pigmentati | 1.23814340 |
| 71 | MP0002067_abnormal_sensory_capabilities | 1.21140715 |
| 72 | MP0001440_abnormal_grooming_behavior | 1.21050870 |
| 73 | MP0001819_abnormal_immune_cell | 1.20945792 |
| 74 | MP0002452_abnormal_antigen_presenting | 1.19938131 |
| 75 | MP0002420_abnormal_adaptive_immunity | 1.19807056 |
| 76 | * MP0001186_pigmentation_phenotype | 1.19348095 |
| 77 | MP0005464_abnormal_platelet_physiology | 1.19336204 |
| 78 | MP0002734_abnormal_mechanical_nocicepti | 1.18262234 |
| 79 | MP0002184_abnormal_innervation | 1.17177018 |
| 80 | MP0003634_abnormal_glial_cell | 1.16415973 |
| 81 | MP0001533_abnormal_skeleton_physiology | 1.16301535 |
| 82 | MP0008569_lethality_at_weaning | 1.16252588 |
| 83 | MP0009785_altered_susceptibility_to | 1.14793524 |
| 84 | MP0004858_abnormal_nervous_system | 1.14680303 |
| 85 | MP0001529_abnormal_vocalization | 1.14363909 |
| 86 | MP0003633_abnormal_nervous_system | 1.13789174 |
| 87 | MP0002557_abnormal_social/conspecific_i | 1.13033172 |
| 88 | MP0001790_abnormal_immune_system | 1.11757440 |
| 89 | MP0005387_immune_system_phenotype | 1.11757440 |
| 90 | MP0010368_abnormal_lymphatic_system | 1.09879418 |
| 91 | MP0005379_endocrine/exocrine_gland_phen | 1.09677762 |
| 92 | MP0001542_abnormal_bone_strength | 1.08747835 |
| 93 | MP0005164_abnormal_response_to | 1.08072078 |
| 94 | MP0002166_altered_tumor_susceptibility | 1.05995419 |
| 95 | MP0000465_gastrointestinal_hemorrhage | 1.04313976 |
| 96 | MP0005166_decreased_susceptibility_to | 0.99940917 |
| 97 | MP0003950_abnormal_plasma_membrane | 0.98720795 |
| 98 | MP0003656_abnormal_erythrocyte_physiolo | 0.97846182 |
| 99 | MP0003195_calcinosis | 0.97764738 |
| 100 | MP0005197_abnormal_uvea_morphology | 0.97743330 |
| 101 | MP0002006_tumorigenesis | 0.97456161 |
| 102 | MP0001845_abnormal_inflammatory_respons | 0.96901724 |
| 103 | MP0001958_emphysema | 0.96637446 |
| 104 | MP0005025_abnormal_response_to | 0.96224497 |
| 105 | MP0004883_abnormal_blood_vessel | 0.94511816 |
| 106 | MP0004484_altered_response_of | 0.93223609 |
| 107 | MP0002090_abnormal_vision | 0.92830093 |
| 108 | MP0008438_abnormal_cutaneous_collagen | 0.92747088 |
| 109 | * MP0001851_eye_inflammation | 0.91796756 |
| 110 | MP0001800_abnormal_humoral_immune | 0.91217706 |
| 111 | MP0003448_altered_tumor_morphology | 0.90161066 |
| 112 | MP0003631_nervous_system_phenotype | 0.89906607 |
| 113 | MP0008260_abnormal_autophagy | 0.89857427 |
| 114 | MP0002405_respiratory_system_inflammati | 0.89684581 |
| 115 | MP0005310_abnormal_salivary_gland | 0.89388809 |
| 116 | MP0002837_dystrophic_cardiac_calcinosis | 0.89168222 |
| 117 | MP0001853_heart_inflammation | 0.87231566 |
| 118 | MP0002229_neurodegeneration | 0.85549878 |
| 119 | MP0001879_abnormal_lymphatic_vessel | 0.85174069 |
| 120 | MP0005253_abnormal_eye_physiology | 0.84726143 |
| 121 | MP0001502_abnormal_circadian_rhythm | 0.84093364 |
| 122 | MP0005167_abnormal_blood-brain_barrier | 0.84063960 |
| 123 | MP0000685_abnormal_immune_system | 0.83274053 |
| 124 | MP0003186_abnormal_redox_activity | 0.83072803 |
| 125 | MP0010234_abnormal_vibrissa_follicle | 0.83029217 |
| 126 | MP0003436_decreased_susceptibility_to | 0.82793958 |
| 127 | MP0003191_abnormal_cellular_cholesterol | 0.82138749 |
| 128 | MP0002877_abnormal_melanocyte_morpholog | 0.82016066 |
| 129 | MP0005451_abnormal_body_composition | 0.81413804 |
| 130 | MP0004924_abnormal_behavior | 0.80821473 |
| 131 | MP0005386_behavior/neurological_phenoty | 0.80821473 |
| 132 | MP0006276_abnormal_autonomic_nervous | 0.80490541 |
| 133 | MP0004142_abnormal_muscle_tone | 0.79060801 |
| 134 | MP0005595_abnormal_vascular_smooth | 0.78822282 |
| 135 | MP0002163_abnormal_gland_morphology | 0.78368196 |
| 136 | MP0004947_skin_inflammation | 0.77457363 |
| 137 | MP0000716_abnormal_immune_system | 0.77025763 |
| 138 | MP0002295_abnormal_pulmonary_circulatio | 0.76987914 |
| 139 | MP0000015_abnormal_ear_pigmentation | 0.76969237 |
| 140 | * MP0002066_abnormal_motor_capabilities/c | 0.75094268 |
| 141 | MP0005174_abnormal_tail_pigmentation | 0.74995066 |
| 142 | MP0005084_abnormal_gallbladder_morpholo | 0.74966842 |
| 143 | MP0003011_delayed_dark_adaptation | 0.74498951 |
| 144 | MP0008469_abnormal_protein_level | 0.72976273 |
| 145 | MP0002909_abnormal_adrenal_gland | 0.71142377 |
| 146 | MP0005275_abnormal_skin_tensile | 0.69587293 |
| 147 | MP0000767_abnormal_smooth_muscle | 0.64036722 |
| 148 | MP0005248_abnormal_Harderian_gland | 0.62862920 |
| 149 | MP0005390_skeleton_phenotype | 0.61966244 |
| 150 | MP0005165_increased_susceptibility_to | 0.61910258 |
| 151 | MP0004272_abnormal_basement_membrane | 0.59791334 |
| 152 | * MP0003795_abnormal_bone_structure | 0.56513001 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Entropion (HP:0000621) | 4.79031548 |
| 2 | Increased cerebral lipofuscin (HP:0011813) | 4.64212475 |
| 3 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 4.51652020 |
| 4 | Hypoplasia of the fovea (HP:0007750) | 4.51652020 |
| 5 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.50533592 |
| 6 | Aplasia/Hypoplasia of the macula (HP:0008059) | 4.49928153 |
| 7 | Double outlet right ventricle (HP:0001719) | 4.44856410 |
| 8 | Congenital malformation of the right heart (HP:0011723) | 4.44856410 |
| 9 | Dysostosis multiplex (HP:0000943) | 4.43704315 |
| 10 | Ocular albinism (HP:0001107) | 4.40330940 |
| 11 | Vacuolated lymphocytes (HP:0001922) | 4.17824654 |
| 12 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 4.11443496 |
| 13 | Abnormality of the fovea (HP:0000493) | 4.10980570 |
| 14 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.99904187 |
| 15 | Mucopolysacchariduria (HP:0008155) | 3.99904187 |
| 16 | Iris hypopigmentation (HP:0007730) | 3.82535647 |
| 17 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.76768030 |
| 18 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.76768030 |
| 19 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.76768030 |
| 20 | Blue irides (HP:0000635) | 3.65344391 |
| 21 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.55628664 |
| 22 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.50849547 |
| 23 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.50849547 |
| 24 | Focal motor seizures (HP:0011153) | 3.48236395 |
| 25 | Albinism (HP:0001022) | 3.43546441 |
| 26 | Abnormality of the periventricular white matter (HP:0002518) | 3.41233333 |
| 27 | Hematochezia (HP:0002573) | 3.32296067 |
| 28 | White forelock (HP:0002211) | 3.32025693 |
| 29 | Poikiloderma (HP:0001029) | 3.27813414 |
| 30 | Abnormality of glycolipid metabolism (HP:0010969) | 3.27346897 |
| 31 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.27346897 |
| 32 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.27346897 |
| 33 | Patchy hypopigmentation of hair (HP:0011365) | 3.26339849 |
| 34 | Generalized hypopigmentation (HP:0007513) | 3.23991790 |
| 35 | Supranuclear gaze palsy (HP:0000605) | 3.19825915 |
| 36 | Recurrent abscess formation (HP:0002722) | 3.15577775 |
| 37 | Myocardial infarction (HP:0001658) | 3.09875042 |
| 38 | Abnormality of macrophages (HP:0004311) | 3.05462277 |
| 39 | Atonic seizures (HP:0010819) | 3.01059765 |
| 40 | Abnormality of the corticospinal tract (HP:0002492) | 2.94696810 |
| 41 | Hypothermia (HP:0002045) | 2.94383443 |
| 42 | Neurofibrillary tangles (HP:0002185) | 2.92456229 |
| 43 | Striae distensae (HP:0001065) | 2.91156674 |
| 44 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.80584368 |
| 45 | Choroideremia (HP:0001139) | 2.79524973 |
| 46 | Abnormality of binocular vision (HP:0011514) | 2.77854769 |
| 47 | Diplopia (HP:0000651) | 2.77854769 |
| 48 | Progressive inability to walk (HP:0002505) | 2.73496657 |
| 49 | Progressive neurologic deterioration (HP:0002344) | 2.69465799 |
| 50 | Congenital sensorineural hearing impairment (HP:0008527) | 2.69028716 |
| 51 | Febrile seizures (HP:0002373) | 2.66800968 |
| 52 | Akinesia (HP:0002304) | 2.64683670 |
| 53 | Eczematoid dermatitis (HP:0000976) | 2.64340641 |
| 54 | Disinhibition (HP:0000734) | 2.62212837 |
| 55 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.61001658 |
| 56 | Abdominal situs inversus (HP:0003363) | 2.58719931 |
| 57 | Abnormality of abdominal situs (HP:0011620) | 2.58719931 |
| 58 | Epileptic encephalopathy (HP:0200134) | 2.57376683 |
| 59 | Heterochromia iridis (HP:0001100) | 2.55683246 |
| 60 | Recurrent bacterial skin infections (HP:0005406) | 2.50966146 |
| 61 | Constricted visual fields (HP:0001133) | 2.50769163 |
| 62 | Slow saccadic eye movements (HP:0000514) | 2.48533142 |
| 63 | Clumsiness (HP:0002312) | 2.48336240 |
| 64 | Pheochromocytoma (HP:0002666) | 2.44036813 |
| 65 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.42249025 |
| 66 | Focal seizures (HP:0007359) | 2.40519080 |
| 67 | Retrobulbar optic neuritis (HP:0100654) | 2.38035410 |
| 68 | Optic neuritis (HP:0100653) | 2.38035410 |
| 69 | Mutism (HP:0002300) | 2.37154591 |
| 70 | Cerebral hemorrhage (HP:0001342) | 2.34849202 |
| 71 | Generalized hypopigmentation of hair (HP:0011358) | 2.33716763 |
| 72 | Ectropion (HP:0000656) | 2.33633592 |
| 73 | Asymmetric septal hypertrophy (HP:0001670) | 2.30467210 |
| 74 | Cutaneous melanoma (HP:0012056) | 2.29844864 |
| 75 | Neuroendocrine neoplasm (HP:0100634) | 2.29686541 |
| 76 | Sensory axonal neuropathy (HP:0003390) | 2.29171202 |
| 77 | Orchitis (HP:0100796) | 2.28904153 |
| 78 | Conjunctival telangiectasia (HP:0000524) | 2.28444609 |
| 79 | Papilledema (HP:0001085) | 2.28114115 |
| 80 | Tetraparesis (HP:0002273) | 2.27147887 |
| 81 | Peritonitis (HP:0002586) | 2.21429955 |
| 82 | Cerebral inclusion bodies (HP:0100314) | 2.21321100 |
| 83 | Generalized tonic-clonic seizures (HP:0002069) | 2.17591438 |
| 84 | Frequent falls (HP:0002359) | 2.15932023 |
| 85 | Global brain atrophy (HP:0002283) | 2.08760832 |
| 86 | Epidermoid cyst (HP:0200040) | 2.07104409 |
| 87 | Purpura (HP:0000979) | 2.06611986 |
| 88 | Abnormal hair whorl (HP:0010721) | 2.05651043 |
| 89 | Stomatitis (HP:0010280) | 2.04419825 |
| 90 | Hepatosplenomegaly (HP:0001433) | 2.04122053 |
| 91 | Freckling (HP:0001480) | 2.03982581 |
| 92 | Congenital stationary night blindness (HP:0007642) | 2.03678118 |
| 93 | Truncal ataxia (HP:0002078) | 2.01236471 |
| 94 | Basal ganglia calcification (HP:0002135) | 1.99671523 |
| 95 | Myositis (HP:0100614) | 1.99510669 |
| 96 | Hemiplegia (HP:0002301) | 1.99246162 |
| 97 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.97727558 |
| 98 | Thick nail (HP:0001805) | 1.96778347 |
| 99 | Hyperventilation (HP:0002883) | 1.96567186 |
| 100 | Hypokinesia (HP:0002375) | 1.96180814 |
| 101 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.95988006 |
| 102 | Pulmonary infiltrates (HP:0002113) | 1.95752623 |
| 103 | Limb hypertonia (HP:0002509) | 1.93843420 |
| 104 | Absence seizures (HP:0002121) | 1.93298758 |
| 105 | Spontaneous hematomas (HP:0007420) | 1.92903787 |
| 106 | Diminished movement (HP:0002374) | 1.91287273 |
| 107 | Progressive visual loss (HP:0000529) | 1.91192134 |
| 108 | Loss of speech (HP:0002371) | 1.90903070 |
| 109 | Gastrointestinal infarctions (HP:0005244) | 1.90855038 |
| 110 | Dialeptic seizures (HP:0011146) | 1.90363160 |
| 111 | Absent frontal sinuses (HP:0002688) | 1.90251980 |
| 112 | Visual hallucinations (HP:0002367) | 1.89970041 |
| 113 | Recurrent skin infections (HP:0001581) | 1.89004973 |
| 114 | Vascular tortuosity (HP:0004948) | 1.86610772 |
| 115 | Gingival bleeding (HP:0000225) | 1.85191190 |
| 116 | Lower limb muscle weakness (HP:0007340) | 1.84744451 |
| 117 | Progressive cerebellar ataxia (HP:0002073) | 1.84708878 |
| 118 | Tongue fasciculations (HP:0001308) | 1.84510247 |
| 119 | Arterial thrombosis (HP:0004420) | 1.82145251 |
| 120 | Follicular hyperkeratosis (HP:0007502) | 1.81933317 |
| 121 | Ovoid vertebral bodies (HP:0003300) | 1.81481649 |
| 122 | Spastic gait (HP:0002064) | 1.81029638 |
| 123 | Ketoacidosis (HP:0001993) | 1.80691529 |
| 124 | Muscle fibrillation (HP:0010546) | 1.80126538 |
| 125 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.79467740 |
| 126 | Osteolytic defects of the hand bones (HP:0009699) | 1.79467740 |
| 127 | Hypopigmentation of the fundus (HP:0007894) | 1.78956409 |
| 128 | Mediastinal lymphadenopathy (HP:0100721) | 1.78194099 |
| 129 | Hypoplasia of the iris (HP:0007676) | 1.77303142 |
| 130 | Corneal dystrophy (HP:0001131) | 1.75357696 |
| 131 | Vertebral compression fractures (HP:0002953) | 1.72669641 |
| 132 | Arterial tortuosity (HP:0005116) | 1.72348957 |
| 133 | Papillary thyroid carcinoma (HP:0002895) | 1.72187981 |
| 134 | Abnormality of DNA repair (HP:0003254) | 1.71534619 |
| 135 | Chronic obstructive pulmonary disease (HP:0006510) | 1.71360227 |
| 136 | Obstructive lung disease (HP:0006536) | 1.71360227 |
| 137 | Widely spaced teeth (HP:0000687) | 1.70849793 |
| 138 | True hermaphroditism (HP:0010459) | 1.69729816 |
| 139 | Petechiae (HP:0000967) | 1.69462989 |
| 140 | Keratitis (HP:0000491) | 1.69179151 |
| 141 | Inability to walk (HP:0002540) | 1.69132897 |
| 142 | Skin nodule (HP:0200036) | 1.69044659 |
| 143 | Prolonged bleeding time (HP:0003010) | 1.68701075 |
| 144 | Oligodontia (HP:0000677) | 1.68234477 |
| 145 | Dysmetria (HP:0001310) | 1.67724119 |
| 146 | Nonprogressive disorder (HP:0003680) | 1.66588542 |
| 147 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.65354341 |
| 148 | Recurrent cutaneous fungal infections (HP:0011370) | 1.65354341 |
| 149 | Spondylolisthesis (HP:0003302) | 1.65114215 |
| 150 | Mitral stenosis (HP:0001718) | 1.65061422 |
| 151 | Mucosal telangiectasiae (HP:0100579) | 1.65013105 |
| 152 | Abnormal eating behavior (HP:0100738) | 1.63890212 |
| 153 | Keratoconjunctivitis (HP:0001096) | 1.63796538 |
| 154 | Inappropriate behavior (HP:0000719) | 1.63083962 |
| 155 | Gowers sign (HP:0003391) | 1.62678100 |
| 156 | Clonus (HP:0002169) | 1.62311383 |
| 157 | Myoclonus (HP:0001336) | 1.61029747 |
| 158 | Axonal loss (HP:0003447) | 1.60588508 |
| 159 | Poor speech (HP:0002465) | 1.59773605 |
| 160 | Spinal muscular atrophy (HP:0007269) | 1.59332298 |
| 161 | Abnormality of the lumbar spine (HP:0100712) | 1.58710375 |
| 162 | Increased CSF protein (HP:0002922) | 1.58337086 |
| 163 | Rigidity (HP:0002063) | 1.58285150 |
| 164 | Myokymia (HP:0002411) | 1.57961117 |
| 165 | Generalized myoclonic seizures (HP:0002123) | 1.57592219 |
| 166 | Agitation (HP:0000713) | 1.57567830 |
| 167 | Keratoconjunctivitis sicca (HP:0001097) | 1.57535099 |
| 168 | Thyroid carcinoma (HP:0002890) | 1.57281946 |
| 169 | T lymphocytopenia (HP:0005403) | 1.57131690 |
| 170 | Abnormality of T cell number (HP:0011839) | 1.57078395 |
| 171 | Decreased central vision (HP:0007663) | 1.56684872 |
| 172 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.56407918 |
| 173 | J-shaped sella turcica (HP:0002680) | 1.55334196 |
| 174 | Metaphyseal dysplasia (HP:0100255) | 1.55180039 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KIT | 4.26320493 |
| 2 | MAP3K3 | 4.22951256 |
| 3 | MAP2K3 | 4.21659570 |
| 4 | FRK | 3.49684515 |
| 5 | RIPK4 | 2.75642104 |
| 6 | PRKD2 | 2.57425659 |
| 7 | PRKCH | 2.53145804 |
| 8 | INSRR | 2.48393419 |
| 9 | ADRBK2 | 2.47161514 |
| 10 | CASK | 2.47028614 |
| 11 | SGK2 | 2.35965346 |
| 12 | MAP3K12 | 2.24506068 |
| 13 | MAPKAPK5 | 2.22785322 |
| 14 | ACVR1B | 2.22281152 |
| 15 | TAOK3 | 2.16888601 |
| 16 | SGK223 | 2.11659812 |
| 17 | SGK494 | 2.11659812 |
| 18 | CDK19 | 2.09302650 |
| 19 | NTRK3 | 2.02076335 |
| 20 | TXK | 1.95185883 |
| 21 | STK24 | 1.92393307 |
| 22 | MAP3K13 | 1.91637989 |
| 23 | SGK3 | 1.71316638 |
| 24 | STK38L | 1.66916856 |
| 25 | IRAK3 | 1.66331459 |
| 26 | FER | 1.65614804 |
| 27 | MAP2K7 | 1.64388089 |
| 28 | MAP3K14 | 1.61266235 |
| 29 | MUSK | 1.60756415 |
| 30 | MAP3K4 | 1.58824662 |
| 31 | TRIB3 | 1.55952858 |
| 32 | CAMKK2 | 1.49912418 |
| 33 | SYK | 1.48460522 |
| 34 | TNIK | 1.42897056 |
| 35 | MARK3 | 1.42183977 |
| 36 | EPHB1 | 1.41310810 |
| 37 | FES | 1.40346992 |
| 38 | BMPR1B | 1.36692683 |
| 39 | MAP4K2 | 1.34613236 |
| 40 | IRAK1 | 1.27530536 |
| 41 | NTRK1 | 1.24043003 |
| 42 | OXSR1 | 1.21500296 |
| 43 | MAP3K9 | 1.19219851 |
| 44 | DDR2 | 1.16182240 |
| 45 | STK3 | 1.16167867 |
| 46 | PRPF4B | 1.16007603 |
| 47 | PDK2 | 1.15144668 |
| 48 | STK39 | 1.13280420 |
| 49 | TGFBR2 | 1.10864732 |
| 50 | MAP4K1 | 1.09133985 |
| 51 | PRKCE | 1.08629128 |
| 52 | CSK | 1.08320028 |
| 53 | EPHA4 | 1.05865789 |
| 54 | TRIM28 | 1.03638001 |
| 55 | BLK | 1.03086444 |
| 56 | SCYL2 | 1.00490684 |
| 57 | IKBKB | 0.99629356 |
| 58 | BCR | 0.97390490 |
| 59 | FGR | 0.96778115 |
| 60 | ZAP70 | 0.95701165 |
| 61 | ABL2 | 0.91548937 |
| 62 | MST4 | 0.89371548 |
| 63 | TBK1 | 0.88979490 |
| 64 | GRK7 | 0.88575502 |
| 65 | JAK1 | 0.86167338 |
| 66 | MAP3K5 | 0.85159341 |
| 67 | BMPR2 | 0.84330139 |
| 68 | IKBKE | 0.83269905 |
| 69 | JAK3 | 0.80989006 |
| 70 | PINK1 | 0.79897647 |
| 71 | KSR1 | 0.78920833 |
| 72 | MOS | 0.78398150 |
| 73 | CDK5 | 0.77837944 |
| 74 | MAPKAPK3 | 0.76963241 |
| 75 | PTK2B | 0.76614512 |
| 76 | PLK2 | 0.75841525 |
| 77 | SIK3 | 0.74730066 |
| 78 | CSNK1G2 | 0.74553020 |
| 79 | ADRBK1 | 0.74340778 |
| 80 | TRPM7 | 0.74081038 |
| 81 | CSNK1A1L | 0.73244308 |
| 82 | GRK5 | 0.73127664 |
| 83 | CAMKK1 | 0.72788544 |
| 84 | TGFBR1 | 0.71280756 |
| 85 | GRK1 | 0.69083511 |
| 86 | MAP2K4 | 0.68993089 |
| 87 | MAPK13 | 0.67823689 |
| 88 | HCK | 0.67802225 |
| 89 | NEK9 | 0.66592362 |
| 90 | LCK | 0.66131638 |
| 91 | MAP3K2 | 0.65609041 |
| 92 | CDK6 | 0.65006962 |
| 93 | ABL1 | 0.64778918 |
| 94 | IRAK2 | 0.64299339 |
| 95 | EPHA3 | 0.64006413 |
| 96 | CSNK1G3 | 0.63992212 |
| 97 | LIMK1 | 0.63813187 |
| 98 | IGF1R | 0.63653081 |
| 99 | PIK3CG | 0.63569526 |
| 100 | MINK1 | 0.63420539 |
| 101 | GRK6 | 0.63199889 |
| 102 | PDK1 | 0.61936350 |
| 103 | NEK6 | 0.61710019 |
| 104 | PAK6 | 0.60962531 |
| 105 | IRAK4 | 0.59316376 |
| 106 | CAMK2B | 0.58388658 |
| 107 | FYN | 0.58161595 |
| 108 | MAPK12 | 0.57762024 |
| 109 | EGFR | 0.56167313 |
| 110 | PDPK1 | 0.55518356 |
| 111 | LYN | 0.54243178 |
| 112 | CAMK2A | 0.53941104 |
| 113 | WEE1 | 0.53233783 |
| 114 | CSNK1G1 | 0.52674358 |
| 115 | MAP2K6 | 0.52542571 |
| 116 | MAP3K6 | 0.51420434 |
| 117 | ARAF | 0.51265462 |
| 118 | TIE1 | 0.50756546 |
| 119 | TNK2 | 0.50574789 |
| 120 | ERBB4 | 0.50183788 |
| 121 | PRKCQ | 0.49857114 |
| 122 | PRKAA2 | 0.49477830 |
| 123 | EIF2AK3 | 0.49424980 |
| 124 | KSR2 | 0.47658750 |
| 125 | MAPK7 | 0.46527349 |
| 126 | MARK1 | 0.45778291 |
| 127 | WNK1 | 0.45337451 |
| 128 | SGK1 | 0.45098043 |
| 129 | ITK | 0.44950013 |
| 130 | PKN1 | 0.44486242 |
| 131 | HIPK2 | 0.44311793 |
| 132 | RET | 0.43832731 |
| 133 | MATK | 0.42518104 |
| 134 | PRKD1 | 0.41674548 |
| 135 | DAPK1 | 0.41575209 |
| 136 | PAK3 | 0.41397502 |
| 137 | FGFR3 | 0.41026712 |
| 138 | MAP2K1 | 0.40516726 |
| 139 | CSF1R | 0.39665023 |
| 140 | MYLK | 0.38736841 |
| 141 | BTK | 0.36715443 |
| 142 | GSK3A | 0.36175139 |
| 143 | TEC | 0.36113395 |
| 144 | JAK2 | 0.35254717 |
| 145 | CAMK2D | 0.35248478 |
| 146 | PAK2 | 0.34605317 |
| 147 | TYK2 | 0.34451705 |
| 148 | ERBB3 | 0.33512931 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Lysosome_Homo sapiens_hsa04142 | 2.52081617 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.35964142 |
| 3 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.35372458 |
| 4 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.27974717 |
| 5 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.01111475 |
| 6 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.90526531 |
| 7 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.84918510 |
| 8 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.80875076 |
| 9 | Nicotine addiction_Homo sapiens_hsa05033 | 1.77342201 |
| 10 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.72076776 |
| 11 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.68252621 |
| 12 | Other glycan degradation_Homo sapiens_hsa00511 | 1.57544388 |
| 13 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.55852688 |
| 14 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.54664976 |
| 15 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.53500182 |
| 16 | Phagosome_Homo sapiens_hsa04145 | 1.51712663 |
| 17 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.50443304 |
| 18 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.46320324 |
| 19 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.45300746 |
| 20 | Long-term potentiation_Homo sapiens_hsa04720 | 1.44946158 |
| 21 | Morphine addiction_Homo sapiens_hsa05032 | 1.43505601 |
| 22 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.42172219 |
| 23 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.41975864 |
| 24 | GABAergic synapse_Homo sapiens_hsa04727 | 1.40422190 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.40194048 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.39445174 |
| 27 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.31319459 |
| 28 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.30456434 |
| 29 | Olfactory transduction_Homo sapiens_hsa04740 | 1.30304131 |
| 30 | Legionellosis_Homo sapiens_hsa05134 | 1.27791432 |
| 31 | Salivary secretion_Homo sapiens_hsa04970 | 1.27612754 |
| 32 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.25255503 |
| 33 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.24009081 |
| 34 | Circadian entrainment_Homo sapiens_hsa04713 | 1.23249634 |
| 35 | Tuberculosis_Homo sapiens_hsa05152 | 1.22386657 |
| 36 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.18335763 |
| 37 | Protein export_Homo sapiens_hsa03060 | 1.17625877 |
| 38 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.16986264 |
| 39 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.15718341 |
| 40 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.14592672 |
| 41 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.14071077 |
| 42 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.14049226 |
| 43 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.14017432 |
| 44 | Taste transduction_Homo sapiens_hsa04742 | 1.10065455 |
| 45 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.10033808 |
| 46 | Leishmaniasis_Homo sapiens_hsa05140 | 1.09149430 |
| 47 | Renin secretion_Homo sapiens_hsa04924 | 1.08932358 |
| 48 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.05216337 |
| 49 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.03266966 |
| 50 | Long-term depression_Homo sapiens_hsa04730 | 1.02543870 |
| 51 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.02208604 |
| 52 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.01312303 |
| 53 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.99857391 |
| 54 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.99207867 |
| 55 | Platelet activation_Homo sapiens_hsa04611 | 0.97868520 |
| 56 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.97662090 |
| 57 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.97493839 |
| 58 | Allograft rejection_Homo sapiens_hsa05330 | 0.96069404 |
| 59 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.95528989 |
| 60 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.95319332 |
| 61 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.94344063 |
| 62 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.93534846 |
| 63 | Malaria_Homo sapiens_hsa05144 | 0.93311143 |
| 64 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.91767255 |
| 65 | Insulin secretion_Homo sapiens_hsa04911 | 0.90336188 |
| 66 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.89923608 |
| 67 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.89147203 |
| 68 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.88755225 |
| 69 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.86726638 |
| 70 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.86724549 |
| 71 | Cocaine addiction_Homo sapiens_hsa05030 | 0.86312572 |
| 72 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.84599419 |
| 73 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.83932082 |
| 74 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.82274484 |
| 75 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.81982205 |
| 76 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.81449981 |
| 77 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.78199540 |
| 78 | Salmonella infection_Homo sapiens_hsa05132 | 0.76490142 |
| 79 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.76080974 |
| 80 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.75920221 |
| 81 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.75701972 |
| 82 | Amoebiasis_Homo sapiens_hsa05146 | 0.74680994 |
| 83 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.74238342 |
| 84 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.73654068 |
| 85 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.72979451 |
| 86 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.72638960 |
| 87 | Pertussis_Homo sapiens_hsa05133 | 0.72392437 |
| 88 | Endocytosis_Homo sapiens_hsa04144 | 0.71311395 |
| 89 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.69388124 |
| 90 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.68847347 |
| 91 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.68495747 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67671364 |
| 93 | Mineral absorption_Homo sapiens_hsa04978 | 0.67609412 |
| 94 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.66491395 |
| 95 | Shigellosis_Homo sapiens_hsa05131 | 0.65696396 |
| 96 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.64951543 |
| 97 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.64743813 |
| 98 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.64158208 |
| 99 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.64137532 |
| 100 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.62906684 |
| 101 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.62420744 |
| 102 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.62108132 |
| 103 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.61155787 |
| 104 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.61119997 |
| 105 | Measles_Homo sapiens_hsa05162 | 0.60437594 |
| 106 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.60434673 |
| 107 | Axon guidance_Homo sapiens_hsa04360 | 0.60398311 |
| 108 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.59881005 |
| 109 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.59550020 |
| 110 | Hepatitis B_Homo sapiens_hsa05161 | 0.57620860 |
| 111 | Glioma_Homo sapiens_hsa05214 | 0.56652563 |
| 112 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.55957315 |
| 113 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.55389695 |
| 114 | Influenza A_Homo sapiens_hsa05164 | 0.54828699 |
| 115 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.53567428 |
| 116 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.52819106 |
| 117 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.52326444 |
| 118 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.51913382 |
| 119 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.51448105 |
| 120 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.51342237 |
| 121 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.51241678 |
| 122 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.51087621 |
| 123 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.50600358 |
| 124 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.50480690 |
| 125 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.49745495 |
| 126 | Focal adhesion_Homo sapiens_hsa04510 | 0.49434479 |
| 127 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.48538121 |
| 128 | Prion diseases_Homo sapiens_hsa05020 | 0.48411363 |
| 129 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48174334 |
| 130 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.48016358 |
| 131 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.47863042 |
| 132 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.47687596 |
| 133 | Melanoma_Homo sapiens_hsa05218 | 0.47609756 |
| 134 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.46360922 |
| 135 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.46133915 |
| 136 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.45923148 |
| 137 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.45346262 |
| 138 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.44972373 |
| 139 | Viral myocarditis_Homo sapiens_hsa05416 | 0.44337177 |
| 140 | Asthma_Homo sapiens_hsa05310 | 0.41466967 |
| 141 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.40339549 |
| 142 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.40271098 |
| 143 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.38940479 |
| 144 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.38940108 |
| 145 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.37431203 |
| 146 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.36529642 |
| 147 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.36404724 |

